Oracle将保健主管Stephen Rusckowski加入其董事会,从2025年11月18日起生效。 Oracle adds healthcare executive Stephen Rusckowski to its board, effective Nov. 18, 2025.

Oracle已任命Stephen Rusckowski为董事会董事,从2025年11月18日起生效,将董事会扩大到14名成员。 Oracle has appointed Stephen Rusckowski to its Board of Directors effective November 18, 2025, expanding the board to 14 members. Rusckowski,前调查诊断和菲利浦保健首席执行官,在保健和技术方面拥有广泛的领导地位。 Rusckowski, former CEO of Quest Diagnostics and Philips Healthcare, brings extensive leadership in healthcare and technology. 目前他在Qiagen N.V.和Baxter International Inc.的董事会任职。 他的任命突显了甲骨文对促进保健创新的重视,特别是通过甲骨文健康促进保健创新。 He currently serves on the boards of Qiagen N.V. and Baxter International Inc. His appointment underscores Oracle’s focus on advancing healthcare innovation, particularly through Oracle Health. 执行局成员任期一年,将在2026年年度会议上连选连任。 Board members serve one-year terms and will be up for re-election at the 2026 annual meeting.